GSK plc
GSKNYSEHealthcare● Active
$50.64
$-0.88(-1.71%)
Market Cap$101.8B
P/E Ratio—
52W High$61.7
52W Low$35.45
GSK plc（GSK）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · GSK · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $5.59B | $2.95B | $6.13B | $5.49B | $3.52B |
| Depreciation & Amort. | $3.70B | $2.55B | $2.85B | $2.64B | $2.12B |
| Stock-Based Comp. | $0.00B | $0.34B | $0.00B | $0.00B | $0.34B |
| Change in Working Capital | ($0.61B) | $2.09B | ($1.06B) | ($1.67B) | $1.39B |
| Net Cash from Operations | $7.14B | $6.55B | $7.89B | $8.16B | $7.95B |
| Investing Activities | |||||
| Capital Expenditure | ($1.32B) | ($2.98B) | ($1.63B) | ($1.41B) | ($2.65B) |
| Purchases of Investments | ($0.09B) | $0.00B | ($0.15B) | ($0.18B) | $0.00B |
| Sales of Investments | $0.20B | $0.02B | $2.37B | $0.29B | $0.02B |
| Net Cash from Investing | ($5.72B) | ($1.23B) | ($2.40B) | ($10.88B) | ($1.78B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($2.51B) | ($2.44B) | ($2.79B) | ($4.27B) | ($4.00B) |
| Debt Issued / Repaid | $1.47B | ($1.17B) | ($2.95B) | ($5.69B) | ($2.00B) |
| Net Cash from Financing | ($1.59B) | ($4.73B) | ($6.07B) | $2.05B | ($7.59B) |
| Free Cash Flow | |||||
| Free Cash Flow | $5.82B | $3.57B | $6.26B | $6.75B | $5.30B |
| FCF Margin %(computed) | 17.83% | 11.38% | 20.63% | 23.03% | 21.45% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · GBP · B
深入了解GSK plc
关于GSK plc（GSK）现金流量表
GSK plc 2025财年经营活动现金流$7.14B，自由现金流$5.82B（FCF利润率17.83%），资本支出($1.32B)。
常见问题
GSK · 4 问GSK plc 2025财年自由现金流$5.82B，同比up63.1%。
GSK free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10